Across the country, Medicaid expansion varies among states. Some experts worried about whether that variation would drive Americans to relocate to other states so that they could obtain better medical coverage. However, those concerns are likely to prove unfounded, according to a recent study from Harvard.
Across the country, Medicaid expansion varies among states. Some experts worried about whether that variation would drive Americans to relocate to other states so that they could obtain better medical coverage. However, those concerns are likely to prove unfounded, according to a recent study from Harvard.
The Harvard School of Public Health concluded that based on research into previous state medical aid expansions, there was no strong evidence that significant migration effects (otherwise known as the “welfare magnet hypothesis”) would occur. Some states were apprehensive about the strain Medicare beneficiary migration might have on their state budgets.
“These results suggest that migration will not be a common way for people to obtain Medicaid coverage under the current expansion and that interstate migration is not likely to be a significant source of costs for states choosing to expand their programs,” read the study. “Our findings are relevant for forecasting the cost and coverage consequences of states’ decisions about expanding Medicaid eligibility.”
Several states, including New Hampshire, Pennsylvania, Missouri, and Utah, are still considering whether to expand Medicaid under the Affordable Care Act.
In other Medicare news, more than 100,000 Americans who became eligible for Medicaid after applying for insurance through HealthCare.gov remain unenrolled due to lingering software defects on the website.
“I think people are resigned to the fact that we have a tremendous amount of work ahead of us in the next few months. It is not going to be easy,” said Thomas Shanahan, spokesperson for the Idaho Department of Health and Welfare. “But we have to get this right from the beginning or the frustration will continue.”
Centers for Medicare & Medicaid Services officials remain committed to resolving the issues these enrollees are experiencing.
Around the Web
Americans Unlikely to Move to Get Better Medicaid Benefits: Study [Reuters]
Status of State Action on the Medicaid Expansion Decision, as of December 11, 2013 [KFF]
HealthCare.gov Defects Leave Many Americans Eligible for Medicaid, CHIP without Coverage
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More